$RichWire Markets and money, explained simply

LIVE

08:46 Credo Technology Shares Fall Sharply Following September Earnings Report 08:35 Artificial Intelligence Dominates Market Focus Once Again 08:29 Nvidia Shares Slide as CEO Jensen Huang Resigns Following Scandal 08:25 Embraer Maintains Buy Rating Following Third-Quarter Performance 08:23 Anthropic Targets $1.4 Trillion Valuation in Upcoming Nasdaq Debut 08:20 Lowe's Positioned for Growth Amid Expanding Home Remodeling Budgets 07:39 Examining OMS Energy Technologies: Balance Sheet Strength and Growth Prospects 07:35 NextEra Energy Emerges as Value Opportunity Amid Utility Sector Pullback 07:34 Carlsmed and the Upcoming Reimbursement Reset 07:32 Evaluating the Risk-Reward Profile of BlackRock MuniHoldings California Quality Fund 07:29 BorgWarner Shifts Propulsion Expertise Toward Data Centers and Industrial Power 07:29 Jenoptik Reports Double-Digit Revenue Growth Amid Semiconductor Surge 08:46 Credo Technology Shares Fall Sharply Following September Earnings Report 08:35 Artificial Intelligence Dominates Market Focus Once Again 08:29 Nvidia Shares Slide as CEO Jensen Huang Resigns Following Scandal 08:25 Embraer Maintains Buy Rating Following Third-Quarter Performance 08:23 Anthropic Targets $1.4 Trillion Valuation in Upcoming Nasdaq Debut 08:20 Lowe's Positioned for Growth Amid Expanding Home Remodeling Budgets 07:39 Examining OMS Energy Technologies: Balance Sheet Strength and Growth Prospects 07:35 NextEra Energy Emerges as Value Opportunity Amid Utility Sector Pullback 07:34 Carlsmed and the Upcoming Reimbursement Reset 07:32 Evaluating the Risk-Reward Profile of BlackRock MuniHoldings California Quality Fund 07:29 BorgWarner Shifts Propulsion Expertise Toward Data Centers and Industrial Power 07:29 Jenoptik Reports Double-Digit Revenue Growth Amid Semiconductor Surge

Topic: AbbVie

REGENXBIO Nears Key Data Release for AbbVie-Partnered Gene Therapy

🧠AI Analysis

AI Analysis8 h ago

REGENXBIO Nears Key Data Release for AbbVie-Partnered Gene Therapy

REGENXBIO announced it is weeks away from reporting top-line clinical data for its RGX-314 gene therapy program, developed in partnership with AbbVie.

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.